Well Health has entered a strategic partnership with AliveCor to enhance cardiac care for Canadian users of the Kardia platform by integrating cardiologist-reviewed ECG services. This collaboration leverages the capabilities of Canadian-registered cardiologists within Kardia’s AI-driven workflow, allowing users to request a Clinician Review after recording an ECG. Reviews are conducted by a cardiologist from WELL’s network and are delivered to the patient within 24 hours, providing critical physician guidance to validate or adjust AI-generated results.

The significance of this partnership lies in its potential to address the growing demand for timely cardiac assessments amid rising elective cardiology wait times, which average 15.3 weeks. By utilizing Health Canada-licensed AI algorithms capable of detecting life-threatening cardiac conditions, the Kardia platform has already recorded over 350 million ECGs. This integration not only enhances patient access to specialized care but also generates clinical services revenue for WELL, thereby expanding its specialist network into the remote cardiac monitoring market.

The takeaway from this development is its potential to shift the paradigm in cardiac diagnostics and management. By combining AI technology with human expertise, this initiative could streamline the diagnostic process, reduce wait times, and improve patient outcomes. Furthermore, the planned future deployment of AliveCor’s Kardia 12L within WELL’s clinic network could significantly broaden point-of-care cardiac diagnostics, positioning both companies at the forefront of innovative healthcare delivery in cardiology. This partnership exemplifies how technology can bridge gaps in specialist availability, ultimately enhancing healthspan through proactive cardiac monitoring and intervention.

Source: longevity.technology